Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Organ Weight / Spleen weight
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / Neutrophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / Transitional B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Monocyte differential count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Monocyte differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.204
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Platelet count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Platelet count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0271
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / Monocytes
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.214
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Monocyte cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Monocyte cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000907
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / Eosinophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / T Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / Follicular B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Eosinophil differential count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Eosinophil differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.909
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Mean platelet volume
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Mean platelet volume
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.518
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN CD25- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0760
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DP T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 CD25- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / NKT Subsets (Q3)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / NK Subsets (Q1)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Eosinophil cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Eosinophil cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.481
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Mean cell volume
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Mean cell volume
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.962
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / cDCs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Hemoglobin
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Hemoglobin
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.456
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Basophil differential count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Basophil differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.392
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / NK Subsets (Q2)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Basophil cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Basophil cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.135
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / B1B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Red blood cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Red blood cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.195
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
8f:7m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / NK cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Hematocrit
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Hematocrit
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.169
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / B2B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / NK Subsets (Q3)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / NK Subsets (Q4)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / MZB
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Neutrophil differential count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Neutrophil differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.433
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Red blood cell distribution width
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Red blood cell distribution width
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.237
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 CD44-CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 CD25- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Neutrophil cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Neutrophil cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0902
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / NKT Subsets (Q1)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Lymphocyte cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Lymphocyte cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
1.70×10-05
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / T cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / RP Macrophage (CD19- CD11c-)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Lymphocyte differential count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / Lymphocyte differential count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.648
|
Successful |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Immunophenotyping / CD4 CD25+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / White blood cell count
|
HOM
|
2f:2m
|
|
|
NotProcessed |
Egr1tm1b(NCOM)Mfgc
|
TCP
|
Hematology / White blood cell count
|
HET
|
8f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.000139
|
Successful |